The Covid-19 vaccine trials being conducted by AstraZeneca and Oxford University have been put on hold after the patient experienced an adverse event. | Lisa Maree Williams/Getty Images
If we want to trust the Covid-19 vaccine, we must be willing to tolerate some bad news.
One of the most promising Covid-19 vaccine candidates, being developed by AstraZeneca and Oxford University, had its Phase 3 trials put on hold after a patient experienced a serious adverse event. That certainly sounds like bad news for everybody eager to have a vaccine as soon as possible.
But hidden in this development is a kernel of good news, if you can call it that: This is exactly the kind of scientific rigor we want biopharma companies to practice — especially amid fears that the US approval of a Covid-19 vaccine could be compromised by politics.
Upstate News Headlines
- South Carolina Reports Highest Daily Total New Covid-19 Infections Friday
- DHEC warns SC at ‘pivotal point’ as state sees highest single-day spike in new virus cases yet
- District: Chase ends with burglary suspect’s arrest on an Upstate school’s property, disrupting dismissal
- TL Hanna apologizes after some parents were upset that they were not able to buy first batch of state championship tickets
- Clemson announces plan to offer COVID-19 testing to community this month
- 72-year-old Lexington SC woman dead after being shot in the face
- Polk County Deputies: Traffic stop turns into drug bust after short struggle with suspect
- Greenville Co. Schools declines rapid COVID-19 tests being offered by state, asks anyone who has symptoms to stay home
- Greenwood police: One injured in shooting on Phoenix St.
- US House votes to decriminalize marijuana at federal level